BioMarker Strategies, LLC - Product Pipeline Analysis

1
BioMarker Strategies, LLC - Product Pipeline
Analysis
One-Stop Shop for Business Information
2
Summary
BioMarker Strategies, LLC (BioMarker Strategies)
is a tissue-based cancer diagnostics company. The
company's product SnapPath, a novel automated
tumor biopsy processing and testing system, is
used to test and analyze a patients live solid
tumor sample at the point of biopsy. Its SnapPath
platform enables the development of PathMap
profiles which help guide targeted drug treatment
selection, including drug combinations. BioMarker
Strategies SnapPath units are being utilized in
human clinical and preclinical studies for
advanced melanoma and other solid tumors. The
company also develops a series of functional,
pathway-based, and ex vivo biomarker tests to
guide an oncologists. BioMarker Strategies is
headquartered in Rockville, Maryland, the
US. This report is a source for data, analysis
and actionable intelligence on the BioMarker
Strategies, LLC portfolio of pipeline products.
3
The report provides detailed analysis on each
pipeline product with information on the
indication, the development stage, trial phase,
product milestones, pipeline territory, estimated
approval date, and estimated launch date. Each
pipeline product is profiled to cover information
on product description, function, technology,
indication, and application. The report is also
supplemented with a detailed company profile and
information on clinical trials, wherever
applicable. This report is built using data and
information sourced from proprietary databases,
primary and secondary research and in-house
analysis by GlobalDatas team of industry
experts.
4
Scope - Detailed company profile with information
on business description, key company facts, major
products and services, key competitors, key
employees, locations and subsidiaries and recent
developments.- Detailed coverage on all the
pipeline products, by equipment type, by therapy
area, by development stage, and by trial phase.-
Information on product milestones and pipeline
territory for each product, the estimated
approval date, and estimated launch date.-
Profile of each pipeline product with additional
information on product description, function,
technology, indication(s), and application.-
Data on relevant clinical trials and product
patent details, wherever applicable.
5

• Reasons to Buy
• Develop business strategies by understanding the
  trends and developments driving the medical
  devices pipeline and technology landscape
  globally.
• Design and develop your product development,
  marketing and sales strategies.
• Exploit MA opportunities by identifying market
  players with the most innovative pipeline.
• Develop market-entry and market expansion
  strategies.
• Exploit in-licensing and out-licensing
  opportunities by identifying products, most
  likely to ensure a robust return.
• - Identify emerging players with potentially
  strong product portfolio and create effective
  counter-strategies to gain competitive advantage.

6
Table Of Content

• Table of Contents 2
• List of Tables 3
• List of Figures 4
• Key Facts 5
• Appendix 31
• Methodology 31
• About GlobalData 31
• Contact Us 31
• Disclaimer 31

7

• To know more
• BioMarker Strategies, LLC - Product Pipeline
  Analysis

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com